Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Prepaid Assets (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Prepaid Assets for 5 consecutive years, with $860000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Prepaid Assets fell 67.15% to $860000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $860000.0, a 67.15% decrease, with the full-year FY2023 number at $1.6 million, up 131.87% from a year prior.
  • Prepaid Assets was $860000.0 for Q3 2024 at Actinium Pharmaceuticals, down from $1.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.3 million in Q2 2023 to a low of $684000.0 in Q4 2022.
  • A 4-year average of $1.7 million and a median of $1.4 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 179.41% in 2023, then tumbled 75.8% in 2024.
  • Actinium Pharmaceuticals' Prepaid Assets stood at $1.5 million in 2021, then crashed by 53.72% to $684000.0 in 2022, then soared by 131.87% to $1.6 million in 2023, then plummeted by 45.78% to $860000.0 in 2024.
  • Per Business Quant, the three most recent readings for ATNM's Prepaid Assets are $860000.0 (Q3 2024), $1.0 million (Q2 2024), and $1.3 million (Q1 2024).